Pure Global: Brazil's AI MedTech Rush—Fast-Track or Data Privacy Trap? copertina

Pure Global: Brazil's AI MedTech Rush—Fast-Track or Data Privacy Trap?

Pure Global: Brazil's AI MedTech Rush—Fast-Track or Data Privacy Trap?

Ascolta gratuitamente

Vedi i dettagli del titolo

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

 This week, we dissect a major regulatory shift in Latin America's largest market. Brazil's ANVISA has just launched RDC 987, a new fast-track approval process for AI-powered medical devices. While this promises to slash market entry timelines, it also introduces complex and unprecedented data privacy requirements tied to the LGPD. This episode explores the dual nature of this regulation. It is both a golden opportunity for tech-forward companies and a potential minefield of compliance. We uncover the hidden challenges that could stall even the most innovative products, turning a supposed shortcut into a costly detour. **Case Study:** Imagine a European AI diagnostics firm, ready to capitalize on Brazil's new fast-track lane. They've prepared their technical dossier, but their submission is suddenly halted. The reason? The patient data used to train their groundbreaking algorithm years ago doesn't meet Brazil's strict new LGPD-based anonymization rules. Their multi-million dollar expansion is now trapped in a web of data compliance they never anticipated. **Key Takeaways:** * What specific documentation is now required under ANVISA's RDC 987? * How can you verify if your AI's legacy training data meets Brazil's new LGPD standards? * Is the "fast-track" a genuine opportunity or a resource trap for non-local companies? * What are the legal liabilities and costs of appointing a local Data Privacy Representative? * Can you leverage your existing FDA or CE marking to simplify this new process? * What are the new post-market surveillance requirements for AI devices under this rule? * How will this change impact reimbursement and market adoption in Brazil? At Pure Global, we specialize in turning these regulatory complexities into clear market access strategies. With our deep local expertise in Brazil and our advanced AI-driven data tools, we help MedTech and IVD companies navigate regulations like RDC 987 efficiently. Our end-to-end solutions cover everything from initial regulatory strategy and technical dossier submission to serving as your official local and data representative. Don't let compliance hurdles block your expansion. Contact us at info@pureglobal.com or visit https://pureglobal.com to learn how we can streamline your entry into over 30 global markets.
Ancora nessuna recensione